ZA200902475B - HCV NS3 Protease Inhibitors - Google Patents

HCV NS3 Protease Inhibitors

Info

Publication number
ZA200902475B
ZA200902475B ZA200902475A ZA200902475A ZA200902475B ZA 200902475 B ZA200902475 B ZA 200902475B ZA 200902475 A ZA200902475 A ZA 200902475A ZA 200902475 A ZA200902475 A ZA 200902475A ZA 200902475 B ZA200902475 B ZA 200902475B
Authority
ZA
South Africa
Prior art keywords
hcv
protease inhibitors
protease
inhibitors
Prior art date
Application number
ZA200902475A
Inventor
Nigel J Liverton
Vincenzo Summa
Francesco Maria Emilia Di
Marco Ferrara
Kevin F Gilbert
Steven Harper
John A Mccauley
Charles J Mcintyre
Alessia Petrocchi
Marco Pompei
Joseph J Romano
Michael T Rudd
Original Assignee
Merck & Co Inc
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Angeletti P Ist Richerche Bio filed Critical Merck & Co Inc
Publication of ZA200902475B publication Critical patent/ZA200902475B/en

Links

ZA200902475A 2006-10-27 2009-04-09 HCV NS3 Protease Inhibitors ZA200902475B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85491206P 2006-10-27 2006-10-27

Publications (1)

Publication Number Publication Date
ZA200902475B true ZA200902475B (en) 2010-03-31

Family

ID=41484197

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200902475A ZA200902475B (en) 2006-10-27 2009-04-09 HCV NS3 Protease Inhibitors

Country Status (3)

Country Link
CN (1) CN101611039A (en)
UA (1) UA95990C2 (en)
ZA (1) ZA200902475B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9624245B2 (en) * 2013-02-07 2017-04-18 Bristol-Myers Squibb Company Macrocyclic compounds as HCV entry inhibitors
EP2964655B1 (en) * 2013-03-07 2018-04-25 Bristol-Myers Squibb Company Macrocyclic compounds for the treatment of hepatitis c
CN108368130B (en) * 2016-05-16 2021-03-02 深圳市塔吉瑞生物医药有限公司 Substituted macrocyclic quinoxaline compound, pharmaceutical composition and application thereof

Also Published As

Publication number Publication date
UA95990C2 (en) 2011-09-26
CN101611039A (en) 2009-12-23

Similar Documents

Publication Publication Date Title
IL198401A0 (en) Hcv ns3 protease inhibitors
EP2083844A4 (en) Hcv ns3 protease inhibitors
EP2079480A4 (en) Hcv ns3 protease inhibitors
EP2079479A4 (en) Hcv ns3 protease inhibitors
EP2076278A4 (en) Hcv ns3 protease inhibitors
HK1121169A1 (en) Hcv ns3 protease inhibitors hcv ns3
EP1879607A4 (en) Hcv ns3 protease inhibitors
EP2271345A4 (en) Hcv ns3 protease inhibitors
HK1210142A1 (en) Hcv protease inhibitors and uses thereof hcv
HK1210141A1 (en) Hcv protease inhibitors and uses thereof hcv
EP1906945A4 (en) Hcv inhibitors
IL189166A0 (en) Macrocyclic peptides as hcv ns3 protease inhibitors
EP2125870A4 (en) Inhibitors of hepatitis c ns3 protease
IL195515A0 (en) Macrocyclic oximyl hepatitis c protease inhibitors
TWI367211B (en) Hcv ns-3 serine protease inhibitors
HK1148739A1 (en) Hcv protease inhibitors hcv
ZA200709987B (en) Combination of HCV protease inhibitors with a surfactant
BRPI0923184A2 (en) hcv ns3 protease inhibitors
IL182339A0 (en) Hcv ns3-ns4a protease inhibition
EP2432318A4 (en) Bimacrocyclic hcv ns3 protease inhibitors
ZA200800072B (en) HCV NS3 Protease inhibitors
EP2064177A4 (en) Protease inhibitors
ZA200902475B (en) HCV NS3 Protease Inhibitors
ZA200800507B (en) Macrocyclic peptides as HCV NS3 protease inhibitors
ZA200711069B (en) HCV inhibitors